Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Fruquintinib and Pirfenidone in Combination With Anti-PD-1 Antibody in Advanced or Metastatic pMMR/MSS Colorectal Carcinoma (NCT06484153) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-07-22 |
Track Combination of Fruquintinib and Anti-PD-1 Antibody Was Reported to Improve Patient Prognosis in Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.